JAMA editor says she was duped by study authors

Share this article:
JAMA editor-in-chief Catherine DeAngelis said she was duped by study authors who failed to disclose ties to drug companies. An AP article revealed that the authors of a study correlating migraines with heart attacks in women had consulted or received research funding from pharmas and had not disclosed their ties, per JAMA policy.
Share this article:
close

Next Article in News

Email Newsletters

More in News

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.

GSK second-quarter sales disappoint

GSK second-quarter sales disappoint

Executives urge analysts to focus on the company's long-term potential.

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union